SQI Diagnostics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SQIDF research report →
Companywww.sqidiagnostics.com
SQI Diagnostics Inc. , a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. It also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test.
- CEO
- Andrew Morris
- IPO
- 2009
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $6.07M
- P/E
- -0.43
- P/S
- 1.03
- P/B
- -0.81
- EV/EBITDA
- -2.32
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 38.30%
- Op Margin
- -241.42%
- Net Margin
- -228.62%
- ROE
- 447.09%
- ROIC
- -302.55%
Growth & Income
- Revenue
- $8.10M · 783.53%
- Net Income
- $-18,523,000 · -75.46%
- EPS
- $-0.05 · -52.24%
- Op Income
- $-19,560,000
- FCF YoY
- -7.26%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.36
- Avg Volume
- 0
Get TickerSpark's AI analysis on SQIDF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SQIDF Coverage
We haven't published any research on SQIDF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SQIDF Report →